Sean Kevlahan, Ph.D., CEO

Oct. 11 | 1:15pm | Rentschler ATMP Ballroom 

Boston, MA


Nanite is a next-generation non-viral gene delivery company developing a new class of programmable polymer nanoparticles for a range of modalities and indications. The company’s AI-driven platform, SAYER™, combines cutting-edge high-throughput experimental and computational methods to design fit-for-purpose delivery vehicles delivering a broad range of genetic cargoes with tissue specificity.

By using this website you agree to accept our Privacy Policy and Terms & Conditions